- +120.2% price growth over the last year
- High gross margin of 84.1%
- Lower volatility than the market (beta 0.33)
Jazz Pharmaceuticals plc stock price ended at $240.97 on Tuesday, after gaining 1.37%
(Updated on Jun 30, 2026)
The Jazz Pharmaceuticals plc stock price gained 1.37% on the last trading day (Tuesday, 30th Jun 2026), rising from $237.72 to $240.97. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 3.05% from a day low at $234.66 to a day high of $241.82. The price has risen in 6 of the last 10 days and is up by 4.5% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 192 thousand more shares were traded than the day before. In total, 886 thousand shares were bought and sold for approximately $213.42 million.
The stock lies in the middle of a wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 24.10% during the next 3 months and, with a 90% probability hold a price between $285.89 and $322.93 at the end of this 3-month period.
JAZZ Signals & Forecast
Mostly positive signals in the chart today. The Jazz Pharmaceuticals plc stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $231.56 and $232.33. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Thursday, June 18, 2026, and so far it has risen 7.26%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Jazz Pharmaceuticals plc stock
On the downside, the stock finds support just below today's level from accumulated volume at $228.57 and $224.66. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Jazz Pharmaceuticals plc finds support just below today's level at $228.57. If this is broken, then the next support from accumulated volume will be at $224.66 and $197.83.
In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $7.16 between high and low, or 3.05%. For the last week the stock has had daily average volatility of 2.95%.
Our recommended stop-loss: $231.73 (-3.83%) (This stock has very low daily movements and this gives very low risk. There is a buy signal from a pivot bottom found 7 days ago.)
Trading Expectations (JAZZ) For The Upcoming Trading Day Of Wednesday 1st
For the upcoming trading day on Wednesday, 1st we expect Jazz Pharmaceuticals plc to open at $239.15, and during the day (based on 14 day Average True Range), to move between $237.70 and $244.24, which gives a possible trading interval of +/-$6.53 (+/-2.75%) up or down from last closing price. If Jazz Pharmaceuticals plc takes out the full calculated possible swing range there will be an estimated 2.75% move between the lowest and the highest trading price during the day.
With no resistance above and support from accumulated volume @ $228.57, some $12.40 (5.15%) from the current price of $240.97, our system finds the risk reward attractive.
Is Jazz Pharmaceuticals plc stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Jazz Pharmaceuticals plc stock to perform well in the short-term.
Current score:
3.892
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on July 1, 2026 - $239.15 ( 0.755%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
JAZZ Performance
Trading levels for JAZZ
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 246.31 | 2.22% |
| R2 | 243.57 | 1.08% |
| R1 | 241.89 | 0.380% |
| Price | 240.97 | |
| S1 | 236.41 | -1.89% |
| S2 | 234.73 | -2.59% |
| S3 | 231.99 | -3.73% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 0 | - |
| Price | 240.97 | |
| S1 | 228.57 | -5.15% |
| S2 | 224.66 | -6.77% |
| S3 | 197.83 | -17.90% |
FAQ
Click here for our free guide on how to buy Jazz Pharmaceuticals plc Stock.
Buy JAZZ
A sell signal from a double top formation was found on Thursday, June 04, 2026 and based on theory for this formation the price should fall by -6.26% to $225.89 within 8 trading days (Tuesday, June 16, 2026) since signal was issued.